Allegheny Financial Group
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1844148
Pittsburgh, PA
Position in LCTX
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$31,600
-$1,800 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allegheny Financial Group holds $1,531,910 across 6 Biotechnology names. LCTX ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,018 | $901,117 | |
| 2 | INSM |
INSMED Inc
|
1,479 | $241,846 | |
| 3 | ANNX |
Annexon, Inc.
|
42,900 | $237,666 | |
| 4 | PGEN |
Precigen, Inc.
|
17,065 | $66,041 | |
| 5 | TSHA |
Taysha Gene Therapies, Inc.
|
12,000 | $53,640 | |
| 6 | LCTX |
Lineage Cell Therapeutics, Inc.
This page
|
20,000 | $31,600 |
All Filings in LCTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,600 | 20,000 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $33,400 | 20,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $33,800 | 20,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $18,200 | 20,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,000 | 20,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,000 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,200 | 20,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,000 | 20,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $29,600 | 20,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $21,800 | 20,000 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $23,600 | 20,000 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $30,000 | 20,000 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $23,400 | 20,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $22,600 | 20,000 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $31,600 | 20,000 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $30,800 | 20,000 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $49,000 | 20,000 | Shares | Sole | 2022-05-11 | |
| 2021-09-30 | $50,400 | 20,000 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $57,000 | 20,000 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $47,000 | 20,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $35,200 | 20,000 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||